Can shedding pounds after breast cancer keep it away?
NCT ID NCT03946423
First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time
Summary
This study looks at whether weight-loss surgery (sleeve gastrectomy) combined with lifestyle changes, or lifestyle changes alone, can help women who have had early-stage breast cancer and are obese. The goal is to see if losing weight might lower the chance of the cancer returning. Participants are women who finished breast cancer treatment at least six months ago, have a BMI of 35 or higher, and are disease-free. The study first checks if women are willing to join and stick with the program for a year, with plans for a larger future trial.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Sleeve gastrectomy (weight-loss surgery) and lifestyle intervention (counseling, diet, exercise)
- What this could lead to
- If successful, this could show that significant weight loss after breast cancer treatment reduces the risk of cancer coming back.
- What could go wrong
- This is a small feasibility study, not a large trial. It may not prove that weight loss prevents recurrence, and surgery carries risks like infection or complications.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EARLY-STAGE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Timing your meals or halving your rice: a new trial tests simple diet hacks for weight loss and blood sugar control
- Does injection location matter for a new Weight-Loss drug? a trial investigates
- Can a new drug boost Semaglutide's power against diabetes and obesity?
- Can a Normal-Weight baseline improve heart risk assessment in type 1 diabetes?
- Skipping the armpit: a trial tests whether partial breast radiation alone is enough
- A daily pill for obesity? zenagamtide faces its biggest test yet.